Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
3.580
+0.030 (0.85%)
Nov 4, 2024, 1:04 PM EST - Market open
Sutro Biopharma Employees
Sutro Biopharma had 302 employees as of December 31, 2023. The number of employees increased by 24 or 8.63% compared to the previous year.
Employees
302
Change (1Y)
24
Growth (1Y)
8.63%
Revenue / Employee
$560,791
Profits / Employee
-$412,086
Market Cap
283.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cerus | 637 |
uniQure | 480 |
ADC Therapeutics | 274 |
Personalis | 225 |
Lyell Immunopharma | 224 |
AC Immune | 161 |
Genfit | 159 |
Sanara MedTech | 108 |
STRO News
- 3 days ago - Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML - GlobeNewsWire
- 24 days ago - Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum - GlobeNewsWire
- 6 weeks ago - Sutro Biopharma's Competitive ADCs Position It For Future Growth In Oncology - Seeking Alpha
- 6 weeks ago - Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024 - GlobeNewsWire
- 7 weeks ago - Sutro Biopharma to Host Research Forum Highlighting Next-Generation ADC Innovation and Near-term Pipeline, on October 10, 2024 - GlobeNewsWire
- 2 months ago - Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer - GlobeNewsWire
- 2 months ago - Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones - GlobeNewsWire